Copyright Decision Should Protect Scientific Publishers

A recent federal court copyright decision should help protect the publishers of scientific and technical journals, according to those involved in the case and other observers. The court's decision in American Geophysical Union, et al. v. Texaco Inc., a test case brought by a group of academic publishers, mandates that permission fees be paid for photocopying done by research scientists in profit-making settings--revenues to which the publishers have long felt entitled. The case will result in

Written byFranklin Hoke
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The court's decision in American Geophysical Union, et al. v. Texaco Inc., a test case brought by a group of academic publishers, mandates that permission fees be paid for photocopying done by research scientists in profit-making settings--revenues to which the publishers have long felt entitled. The case will result in long-term benefits to scientists, the sources say, in the form of continuing, even expanded, access to publishing outlets for their work because journal publishers will be more secure financially with the additional permission income.

At the same time, investigators in private research environments will still be able to get the copies of journal articles they need for their work, although at a cost to their companies, say these sources.

In his July 22 opinion, Judge Pierre N. Leval of the United States District Court, Southern District of New York, wrote that researchers working for profit-making companies do not have the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies